SOPHiA GENETICS SA

NASDAQ
SOPH
Stock
Yield per half year: -12.31%
Dividend yield: 0%
Sector: Healthcare

Share chart SOPHiA GENETICS SA

About SOPHiA GENETICS SA

Sophia Genetics SA, облачная платформа «программное обеспечение как услуга», которая позволяет медицинским учреждениям получать информацию из своих данных. Компания предлагает SOPHiA DDM для лечения солидных опухолей. Sophia Genetics SA была основана в 2012 году и базируется в Сен-Сюльпис, Швейцария.

Main settings

IPO date 2021-07-23
ISIN CH1125843347
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт link
Цена ао 2.85
Change price per day: 0% (2.85)
Change price per week: -0.3497% (2.86)
Change price per month: -6.56% (3.05)
Change price per 3 month: -27.48% (3.93)
Change price per half year: -12.31% (3.25)
Change price per year: -39.75% (4.73)
Change price per 3 year: -22.97% (3.7)
Change price per year to date: -9.81% (3.16)

Grade

Underestimation
Title Value Grade
P/S 3.11 5
P/BV 2.1 7
P/E 0 0
EV/EBITDA -2.96 0
Total: 5.25
Efficiency
Title Value Grade
ROA, % -34.58 0
ROE, % -50.41 0
Total: 0
Dividends
Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0
Debt
Title Value Grade
Debt/EBITDA -0.5833 10
Total: 9.6
Growth impulse
Title Value Grade
Yield Revenue, % 132.76 10
Yield Ebitda, % 48.38 6
Yield EPS, % 15.36 3
Total: 6.6

Main owners

Similar companies



Company management

Head Job title Payment Year of birth
Dr. Jurgi Camblong M.B.A., Ph.D. Co-Founder, CEO & Director 1.08M 1978 (47 years)
Mr. Ross Jordan Muken B.Sc. Executive VP, CFO & COO N/A 1981 (44 years)
Mr. Abhimanyu Verma Senior VP & CTO N/A
Dr. Zhenyu Xu Ph.D. Executive VP & Chief Scientific Officer N/A 1983 (42 years)
Mr. Daan van Well L.L.M., M.B.A. Executive VP, Chief Legal & Compliance Officer N/A 1975 (50 years)
Ms. Manuela Da Silva Valente B.A. Executive VP & Chief People Officer N/A 1971 (54 years)
Dr. Philippe Menu M.B.A., M.D., Ph.D. Executive VP, Chief Medical Officer & Chief Product Officer N/A 1982 (43 years)
Katherine Bailon Vice President of Investor Relations N/A
Mr. Kevin Puylaert VP & MD of EMEA N/A

About company

Address: Switzerland, Saint-Sulpice, Rue du Centre 172 - Open in google maps, Open in yandex maps
Website: https://www.sophiagenetics.com